Evaluating covid-19 vaccine efficacy and safety in the post-authorisation phase.
PublisherBMJ Publishing Group
MetadataShow full item record
- COVID-19 vaccine strategies must focus on severe disease and global equity.
- Authors: McIntyre PB, Aggarwal R, Jani I, Jawad J, Kochhar S, MacDonald N, Madhi SA, Mohsni E, Mulholland K, Neuzil KM, Nohynek H, Olayinka F, Pitisuttithum P, Pollard AJ, Cravioto A
- Issue date: 2022 Jan 22
- Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021.
- Authors: Tabak YP, Sun X, Brennan TA, Chaguturu SK
- Issue date: 2021 Dec 1
- Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.
- Authors: Lim HX, Arip M, Yahaya AAA, Jazayeri SD, Poppema S, Poh CL
- Issue date: 2021 Nov 30
- COVID-19 Vaccine: Promoting Vaccine Acceptance.
- Authors: Laine C, Cotton D, Moyer DV
- Issue date: 2021 Feb
- Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis.
- Authors: Tran S, Truong TH, Narendran A
- Issue date: 2021 Dec